Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Winder

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Anticancer Research|June 23, 2023
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An UpdateEwald Wöll, Arno Amann, Wolfgang Eisterer, et al.
Annals of Hematology|June 18, 2026
Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic reviewMagdalena Benda, Patrick Reimann, Wolfgang Willenbacher, et al.
BMC Cancer|January 19, 2012
A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patientsAlois H Lang, Simone Geller-Rhomberg, Thomas Winder, et al.
Oncology Reports|April 11, 2009
Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancerThomas Winder, Axel Mündlein, Simone Rhomberg, et al.
Bone Reports|August 14, 2024
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot studyMichael Mark, Alfonso Rojas Mora, Thomas Winder, et al.
Frontiers in Immunology|July 5, 2021
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis PatientsEmanuel Zitt, Tamara Davidovic, Judith Schimpf, et al.
Experimental and Molecular Pathology|February 20, 2017
Detecting circulating tumor DNA in renal cancer: An open challengeClaudia Corrò, Tomas Hejhal, Cédric Poyet, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicityDongyun Yang, Andrew Hendifar, Cosima Lenz, et al.
Frontiers in Oncology|September 15, 2023
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statementHossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, et al.
Oncology Research and Treatment|August 5, 2021
Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement ArticleAlexander R Siebenhüner, Sara De Dosso, Daniel Helbling, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Anticancer Research|June 23, 2023
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An UpdateEwald Wöll, Arno Amann, Wolfgang Eisterer, et al.
Annals of Hematology|June 18, 2026
Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic reviewMagdalena Benda, Patrick Reimann, Wolfgang Willenbacher, et al.
BMC Cancer|January 19, 2012
A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patientsAlois H Lang, Simone Geller-Rhomberg, Thomas Winder, et al.
Oncology Reports|April 11, 2009
Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancerThomas Winder, Axel Mündlein, Simone Rhomberg, et al.
Bone Reports|August 14, 2024
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot studyMichael Mark, Alfonso Rojas Mora, Thomas Winder, et al.
Frontiers in Immunology|July 5, 2021
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis PatientsEmanuel Zitt, Tamara Davidovic, Judith Schimpf, et al.
Experimental and Molecular Pathology|February 20, 2017
Detecting circulating tumor DNA in renal cancer: An open challengeClaudia Corrò, Tomas Hejhal, Cédric Poyet, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicityDongyun Yang, Andrew Hendifar, Cosima Lenz, et al.
Frontiers in Oncology|September 15, 2023
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statementHossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, et al.
Oncology Research and Treatment|August 5, 2021
Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement ArticleAlexander R Siebenhüner, Sara De Dosso, Daniel Helbling, et al.
Pageof 10